共 50 条
- [21] 70 Kinetics of minimal residual disease (MRD) in high-risk (HR) childhood acute lymphoblastic leukemia during HR-treatment and before stem cell transplantation in the ongoing trial ALL-BFM 2000LEUKEMIA, 2003, 17 (03) : 673 - 673Schrauder, AFlohr, TKoch, DFaye-Lund, IStanulla, MZimmermann, WWelte, KBartram, CRSchrappe, M
- [22] Risk of infections in induction therapy of childhood acute lymphoblastic leukemia with dexamethasone as compared to prednisone: Experience with 316 patients from a prospective comparison in trial ALL-BFM 2000.BLOOD, 2001, 98 (11) : 114A - 114ABeier, RReiter, AZimmermann, MSchrappe, M
- [23] Pediatric Patients with High-Risk B-Cell ALL in First Complete Remission May Benefit from Less Toxic Immunotherapy with Blinatumomab - Results from Randomized Controlled Phase 3 Trial AIEOP-BFM ALL 2017BLOOD, 2023, 142Schrappe, MartinLocatelli, FrancoValsecchi, Maria GraziaCario, GunnarVossen-Gajcy, MichaelaStary, JanAttarbaschi, AndisheBodmer, NicoleBarbaric, DragaElitzur, SarahSilvestri, DanielaKolenova, AlexandraMoericke, AnjaBourquin, Jean-PierreDalla-Pozza, LucianoStanulla, MartinIzraeli, ShaiRizzari, CarmeloPoyer, Fionavon Stackelberg, ArendConter, ValentinoZimmermann, MartinBiondi, Andrea
- [24] Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized StudyJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (08) : 915 - 926Conter, ValentinoValsecchi, Maria GraziaCario, GunnarZimmermann, MartinAttarbaschi, AndisheStary, JanNiggli, FelixDalla Pozza, LucianoElitzur, SarahSilvestri, DanielaLocatelli, FrancoMoericke, AnjaEngstler, GernotSmisek, PetrBodmer, NicoleBarbaric, DragaIzraeli, ShaiRizzari, CarmeloBoos, JoachimBuldini, BarbaraZucchetti, Massimovon Stackelberg, ArendMatteo, CristinaLehrnbecher, ThomasLanvers-Kaminsky, ClaudiaCazzaniga, GiovanniGruhn, BerndBiondi, AndreaSchrappe, Martin
- [25] ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - PRE-BMT PROGNOSTIC FACTORS PREDICT IMPROVED DISEASE-FREE SURVIVALJOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 221 - 221WEISDORF, DJNESBIT, MERAMSAY, NKCMCGLAVE, PBWOODS, WGHURD, DDKIM, TGOLDMAN, AKERSEY, J
- [26] Risk-adjusted therapy ofAcute lymphoblastic leukemia can decrease treatment burden and improve survival: Treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95BLOOD, 2007, 110 (11) : 180A - 180AMoricke, AnjaReiter, AlfredZimmermann, MartinGadner, HelmutStanulla, MartinLudwig, Wolf-DieterHarbott, JochenMann, GeorgNiggli, FelixHenze, GunterWelte, KarlKlingebiel, ThomasNiemeyer, CharlotteZintl, FelixRiehm, HansjorgSchrappe, Martin
- [27] Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival:: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95BLOOD, 2008, 111 (09) : 4477 - 4489Moericke, AnjaReiter, AlfredZimmermann, MartinGadner, HelmutStanulla, MartinDoerdelmann, MichaelLoening, LutzBeier, RitaLudwig, Wolf-DieterRatei, RichardHarbott, JochenBoos, JoachimMann, GeorgNiggli, FelixFeldges, AndreasHenze, GuenterWelte, KarlBeck, Joern-DirkKlingebiel, ThomasNiemeyer, CharlotteZintl, FelixBode, UdoUrban, ChristianWehinger, HelmutNiethammer, DietrichRiehm, HansjoergSchrappe, Martin
- [28] Haploidentical hematopoietic SCT may be superior to conventional consolidation/maintenance chemotherapy as post-remission therapy for high-risk adult ALLBONE MARROW TRANSPLANTATION, 2015, 50 (01) : 20 - 25Sun, Y-QWang, J.Jiang, Q.Xu, L-PLiu, D-HZhang, X-HLiu, K-YHuang, X-J
- [29] Haploidentical hematopoietic SCT may be superior to conventional consolidation/maintenance chemotherapy as post-remission therapy for high-risk adult ALLBone Marrow Transplantation, 2015, 50 : 20 - 25Y-q SunJ WangQ JiangL-p XuD-h LiuX-h ZhangK-y LiuX-j Huang
- [30] Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trialLeukemia, 2020, 34 : 1694 - 1700Andishe AttarbaschiGeorg MannMartin ZimmermannPeter BaderElena BarisoneGiuseppe BassoAndrea BiondiGunnar CarioGianni CazzanigaAntonella ColombiniChristian FlothoMichaela KuhlenPeter LangMelchior LautenChristin LinderkampFranco LocatelliLuca Lo NigroAnja MörickeFelix NiggliRenate Panzer-GrümayerRosanna ParasoleChristina PetersMaria Caterina PuttiCarmelo RizzariMeinolf SuttorpMaria Grazia ValsecchiValentino ConterMartin Schrappe